Navigation Links
Bend Research Offers Broad Access to Drug-Delivery Solutions

BEND, Ore., Oct. 20 /PRNewswire/ -- Bend Research Inc. announced today that it will independently offer unique drug-delivery expertise and technologies to outside firms in the pharmaceutical and biotechnology industries.

Bend Research will continue its 23-year collaboration with Pfizer but will also be free to work with outside firms using proprietary technologies developed jointly by the two firms.

These technologies include the spray-dried dispersion (SDD) technology (which increases the oral bioavailability of low-solubility compounds), controlled-release, multiparticulate, and pulmonary delivery platforms.

Bend Research CEO Rod Ray commented: "Our work with Pfizer has helped us tremendously to grow and develop our capabilities over the past two decades. In return, we have helped Pfizer advance a significant number of their compounds. Today, we're pleased to have the opportunity to collaborate with additional clients to enable the delivery of new medicines."

Kelvin Cooper, Senior Vice President of Worldwide Pharmaceutical Sciences for Pfizer Global Research and Development, agreed: "Our collaboration with Bend Research has proved to be valuable and we look forward to continued work with Bend Research. Through this agreement, we hope the technologies we've developed together will help speed the introduction of new medicines to patients throughout the world."

Under terms of the agreement with Pfizer, Bend Research will have the ability to employ expertise and processes developed with Pfizer to benefit other drug developers. These include optimized drug discovery, dosage form development, engineering capabilities, and manufacture of supplies for clinical trials under Good Manufacturing Practice (GMP) conditions.

Bend Research will continue to work exclusively with Pfizer on certain specific technology platforms. This commitment reaffirms the strong relationship between the two companies while providing enabling technologies for improved world health

About Bend Research Inc.

Bend Research Inc. is an interdisciplinary technology-, science-, and engineering-driven company that discovers, advances, develops, and commercializes pharmaceutical and healthcare products through the application of technology platforms. This capability is driven by scientific and engineering excellence. The company has three facilities based in Bend, Oregon.

SOURCE Bend Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
2. The Wellness Community Announces National Cancer Survivorship Research & Training Institute in Philadelphia
3. Research May Help Predict Preeclampsia
4. Georgetown University Med Center reproductive health researchers tackle public health concerns
5. Monash wins $32m for health and medical research
6. New research shows that the smell of smoke does not trigger relapse in quitters
7. Stem-cell sentry sounds the alarm to maintain balance between cancer and aging, U-M researchers find
8. American Cancer Society awards research grants to 116 investigators at 75 institutions nationwide
9. Steroids aid recovery from pneumonia, UT Southwestern researchers say
10. Carnegie Mellon International Autism Symposium to Feature Groundbreaking Research, Oct. 17-18
11. MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... The American Society for Clinical Pathology ... World AIDS Day 2015. On Nov. 30, ASCP shared its “Give a minute. Get ... AIDS Day and the importance of getting tested for HIV. , ASCP has asked ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... While powdered ... results in wasted time. Fortunately, an inventor from Chesterfield, Va., has found an easy ... to keep the scoop used to measure powdered contents in a canister or other ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... to its industry-leading suite of automated breast density assessment and enterprise analytics ... meeting, November 29-December 4, 2015 (South Hall booth #2377). Volpara’s quantitative breast ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming Dec. 8 virtual ... Essentia Health and UCare, MissionPoint Health Partners, and Intel Corp. Leaders from ...
(Date:11/30/2015)... ... November 30, 2015 , ... Insightra Medical, Inc. ... Surgical Mesh technology for soft tissue repair in the US via Insightra’s national ... resorbable surgical mesh intended to support and reinforce soft tissue for 6-9 months ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Belgium , Nov. 30, 2015   VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... present at the LD Micro Conference, which will be held ... Attending from VolitionRx will be David Kratochvil ... , Vice President of Investor Relations. ® ...
(Date:11/30/2015)... Israel , Nov. 30, 2015 /PRNewswire/ ... on acquiring and developing innovative therapies for ear, nose, ... Keith A. Katkin as chairman of the ... , chief executive officer for OticPharma, Ltd.  "Keith brings ... chairman, he will be able to share this experience ...
(Date:11/29/2015)... 29, 2015   Royal Philips  (NYSE: PHG, AEX: ... at the 2015 Radiological Society of North America Annual ... Place in Chicago . Visitors to ... company,s broad portfolio of integrated Diagnostic Imaging, Clinical Informatics, ... clinical performance, improve workflow and create a superior patient ...
Breaking Medicine Technology: